Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
164.83
+4.00 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
Krystal Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 373.97 | 358.33 | 161.9 | 341.25 | 268.27 | 187.51 | Upgrade
|
| Short-Term Investments | 214.36 | 173.85 | 217.27 | 96.85 | 2.99 | 6.17 | Upgrade
|
| Cash & Short-Term Investments | 588.32 | 532.18 | 379.17 | 438.1 | 271.26 | 193.69 | Upgrade
|
| Cash Growth | 4.67% | 40.35% | -13.45% | 61.50% | 40.05% | 73.30% | Upgrade
|
| Receivables | 97.3 | 42.04 | - | - | - | - | Upgrade
|
| Inventory | 18.58 | 6.99 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 8.96 | 6.71 | 4.61 | 4.17 | 3.8 | 2.2 | Upgrade
|
| Total Current Assets | 713.16 | 587.91 | 383.78 | 442.27 | 275.06 | 195.88 | Upgrade
|
| Property, Plant & Equipment | 163.06 | 168.23 | 169.73 | 119.58 | 34.17 | 11.18 | Upgrade
|
| Long-Term Investments | 105.89 | 61.95 | 4.62 | 64.37 | - | 0.5 | Upgrade
|
| Other Long-Term Assets | 0.2 | 0.26 | 0.32 | 0.07 | 1.61 | 1.46 | Upgrade
|
| Total Assets | 982.32 | 818.36 | 558.45 | 626.3 | 310.84 | 209.02 | Upgrade
|
| Accounts Payable | 5.58 | 4.13 | 3.98 | 8.4 | 2.11 | 1.02 | Upgrade
|
| Accrued Expenses | 43.36 | 17.81 | 11.54 | 6.52 | 3.99 | 1.51 | Upgrade
|
| Current Portion of Leases | 1.29 | 1.47 | 1.56 | 1.04 | 0.64 | 0.48 | Upgrade
|
| Current Income Taxes Payable | 0.57 | 2.28 | 0.04 | 0.08 | 0.04 | 0.04 | Upgrade
|
| Other Current Liabilities | 38.73 | 7.39 | 11.72 | 9.69 | 8.68 | 0.28 | Upgrade
|
| Total Current Liabilities | 89.53 | 33.09 | 28.85 | 25.74 | 15.45 | 3.33 | Upgrade
|
| Long-Term Leases | 6.18 | 6.62 | 7.37 | 6.98 | 3.31 | 2.78 | Upgrade
|
| Other Long-Term Liabilities | 0.76 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 96.47 | 39.71 | 36.22 | 32.72 | 18.76 | 6.11 | Upgrade
|
| Additional Paid-In Capital | 1,110 | 1,048 | 803.72 | 734.52 | 363.29 | 241.95 | Upgrade
|
| Retained Earnings | -226.15 | -269.83 | -280.76 | -140.78 | -71.21 | -39.05 | Upgrade
|
| Comprehensive Income & Other | 1.51 | 0.64 | -0.73 | -0.16 | 0.01 | 0.01 | Upgrade
|
| Total Common Equity | 885.85 | 778.64 | 522.23 | 593.58 | 292.08 | 202.91 | Upgrade
|
| Shareholders' Equity | 885.85 | 778.64 | 522.23 | 593.58 | 292.08 | 202.91 | Upgrade
|
| Total Liabilities & Equity | 982.32 | 818.36 | 558.45 | 626.3 | 310.84 | 209.02 | Upgrade
|
| Total Debt | 7.48 | 8.09 | 8.93 | 8.02 | 3.95 | 3.26 | Upgrade
|
| Net Cash (Debt) | 686.74 | 586.04 | 374.86 | 494.44 | 267.32 | 190.42 | Upgrade
|
| Net Cash Growth | 16.34% | 56.34% | -24.19% | 84.97% | 40.38% | 70.38% | Upgrade
|
| Net Cash Per Share | 23.31 | 21.12 | 14.71 | 22.28 | 14.23 | 11.98 | Upgrade
|
| Filing Date Shares Outstanding | 28.76 | 28.29 | 25.76 | 25.21 | 22.19 | 17.36 | Upgrade
|
| Total Common Shares Outstanding | 28.76 | 28.24 | 25.76 | 25.21 | 19.71 | 17.35 | Upgrade
|
| Working Capital | 623.64 | 554.82 | 354.93 | 416.53 | 259.61 | 192.55 | Upgrade
|
| Book Value Per Share | 30.80 | 27.58 | 20.27 | 23.55 | 14.82 | 11.69 | Upgrade
|
| Tangible Book Value | 885.85 | 778.64 | 522.23 | 593.58 | 292.08 | 202.91 | Upgrade
|
| Tangible Book Value Per Share | 30.80 | 27.58 | 20.27 | 23.55 | 14.82 | 11.69 | Upgrade
|
| Buildings | 111.44 | 111.18 | - | - | - | - | Upgrade
|
| Machinery | 33.8 | 30.49 | 12.93 | 6.51 | 5.58 | 3.72 | Upgrade
|
| Construction In Progress | 5.5 | 7.29 | 131.33 | 104.34 | 23.03 | 2.43 | Upgrade
|
| Leasehold Improvements | 25.64 | 25.07 | 24.22 | 5.72 | 4.63 | 3.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.